IBDEI1TY ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31082,1,3,0)
 ;;=3^Hallucinogen Induced Anxiety Disorder w/ Mod/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,31082,1,4,0)
 ;;=4^F16.280
 ;;^UTILITY(U,$J,358.3,31082,2)
 ;;=^5003345
 ;;^UTILITY(U,$J,358.3,31083,0)
 ;;=F16.980^^123^1558^3
 ;;^UTILITY(U,$J,358.3,31083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31083,1,3,0)
 ;;=3^Hallucinogen Induced Anxiety Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,31083,1,4,0)
 ;;=4^F16.980
 ;;^UTILITY(U,$J,358.3,31083,2)
 ;;=^5003357
 ;;^UTILITY(U,$J,358.3,31084,0)
 ;;=F16.14^^123^1558^4
 ;;^UTILITY(U,$J,358.3,31084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31084,1,3,0)
 ;;=3^Hallucinogen Induced Bipolar Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,31084,1,4,0)
 ;;=4^F16.14
 ;;^UTILITY(U,$J,358.3,31084,2)
 ;;=^5003328
 ;;^UTILITY(U,$J,358.3,31085,0)
 ;;=F16.24^^123^1558^5
 ;;^UTILITY(U,$J,358.3,31085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31085,1,3,0)
 ;;=3^Hallucinogen Induced Bipolar Disorder w/ Mod/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,31085,1,4,0)
 ;;=4^F16.24
 ;;^UTILITY(U,$J,358.3,31085,2)
 ;;=^5003341
 ;;^UTILITY(U,$J,358.3,31086,0)
 ;;=F16.94^^123^1558^6
 ;;^UTILITY(U,$J,358.3,31086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31086,1,3,0)
 ;;=3^Hallucinogen Induced Bipolar Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,31086,1,4,0)
 ;;=4^F16.94
 ;;^UTILITY(U,$J,358.3,31086,2)
 ;;=^5003353
 ;;^UTILITY(U,$J,358.3,31087,0)
 ;;=F16.159^^123^1558^7
 ;;^UTILITY(U,$J,358.3,31087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31087,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,31087,1,4,0)
 ;;=4^F16.159
 ;;^UTILITY(U,$J,358.3,31087,2)
 ;;=^5003331
 ;;^UTILITY(U,$J,358.3,31088,0)
 ;;=F16.259^^123^1558^8
 ;;^UTILITY(U,$J,358.3,31088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31088,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic Disorder w/ Mod/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,31088,1,4,0)
 ;;=4^F16.259
 ;;^UTILITY(U,$J,358.3,31088,2)
 ;;=^5003344
 ;;^UTILITY(U,$J,358.3,31089,0)
 ;;=F16.959^^123^1558^9
 ;;^UTILITY(U,$J,358.3,31089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31089,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,31089,1,4,0)
 ;;=4^F16.959
 ;;^UTILITY(U,$J,358.3,31089,2)
 ;;=^5003356
 ;;^UTILITY(U,$J,358.3,31090,0)
 ;;=F16.99^^123^1558^20
 ;;^UTILITY(U,$J,358.3,31090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31090,1,3,0)
 ;;=3^Phencyclidine Use Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,31090,1,4,0)
 ;;=4^F16.99
 ;;^UTILITY(U,$J,358.3,31090,2)
 ;;=^5133359
 ;;^UTILITY(U,$J,358.3,31091,0)
 ;;=F11.10^^123^1559^23
 ;;^UTILITY(U,$J,358.3,31091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31091,1,3,0)
 ;;=3^Opioid Use Disorder,Mild
 ;;^UTILITY(U,$J,358.3,31091,1,4,0)
 ;;=4^F11.10
 ;;^UTILITY(U,$J,358.3,31091,2)
 ;;=^5003114
 ;;^UTILITY(U,$J,358.3,31092,0)
 ;;=F11.129^^123^1559^19
 ;;^UTILITY(U,$J,358.3,31092,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31092,1,3,0)
 ;;=3^Opioid Intoxication w/o Perceptual Disturbances;Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,31092,1,4,0)
 ;;=4^F11.129
 ;;^UTILITY(U,$J,358.3,31092,2)
 ;;=^5003118
 ;;^UTILITY(U,$J,358.3,31093,0)
 ;;=F11.14^^123^1559^27
 ;;^UTILITY(U,$J,358.3,31093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31093,1,3,0)
 ;;=3^Opioid-Induced Depressive Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,31093,1,4,0)
 ;;=4^F11.14
 ;;^UTILITY(U,$J,358.3,31093,2)
 ;;=^5003119
 ;;^UTILITY(U,$J,358.3,31094,0)
 ;;=F11.182^^123^1559^29
